ReachMD

Be part of the knowledge.™

Oncology and Hematology

1925

LikeLikedUnlike

- Pavani Chalasani MD, MPH
  Peer
- Nan Chen, MD
  Peer
0
Project Oncology®
The Emerging Role of Immunotherapy in Triple-Negative Breast Cancer
The Emerging Role of Immunotherapy in Triple-Negative Breast Cancer
- Pavani Chalasani MD, MPH
  Peer
- Seema A. Khan, MD
  Peer
0
Project Oncology®
Treating Metastatic Breast Cancer: Where Are We Now?
Treating Metastatic Breast Cancer: Where Are We Now?
- Jacob Sands, MD
  Peer
- Maya Leiva, PharmD, BCOP
  Peer
0
Project Oncology®
Exploring Drug Shortages in the U.S.: What Do We Need to Know?
Exploring Drug Shortages in the U.S.: What Do We Need to Know?
- Jacob Sands, MD
  Peer
- Maya Leiva, PharmD, BCOP
  Peer
0
Project Oncology®
Bridging the Gaps in Care: How to Improve Care for LGBTQ+ Patients
Bridging the Gaps in Care: How to Improve Care for LGBTQ+ Patients
- Pavani Chalasani MD, MPH
  Peer
- Kevin Kalinsky MD, MS
  Peer
0
Project Oncology®
Conversations Around Chemotherapy: Do All of Your Patients Need It?
Conversations Around Chemotherapy: Do All of Your Patients Need It?
- Jacob Sands, MD
  Peer
- Marie Wood, MD
  Peer
0
Project Oncology®
Combatting Breast Cancer with Chemoprevention
Combatting Breast Cancer with Chemoprevention

- Eric Edell, MD, FCCP
  Peer
- Septimiu Murgu, MD, FCCP
  Peer
- Narjust Duma, MD
  Peer
- Christopher Hartley, MD
  Peer
- Jeffrey Mueller, DO
  Peer
3
CME/CE
Optimal Tissue Acquisition, Handling, and Processing NGS and PD-L1 Testing
Optimal Tissue Acquisition, Handling, and Processing NGS and PD-L1 Testing
1.25 credits
- Luis Paz-Ares, MD, PhD
  Peer
- Kristen Marrone, MD
  Peer
3
CME/CE
Empowering Clinicians to Optimize Patient Outcomes: Addressing Global Challenges in the Use of Immunotherapy in NSCLC
Empowering Clinicians to Optimize Patient Outcomes: Addressing Global Challenges in the Use of Immunotherapy in NSCLC
0.50 credits
- Elizabeth Smyth, MD
  Peer
- Jaffer Ajani, MD
  Peer
3
CME/CE
Optimal Standards of Care for Second-Line HER2-Positive Advanced Gastric and GEJ Cancers
Optimal Standards of Care for Second-Line HER2-Positive Advanced Gastric and GEJ Cancers
0.25 credits
- Septimiu Murgu, MD, FCCP
  Peer
- Eric Edell, MD, FCCP
  Peer
- Nichole Tanner, MD, MS, FCCP
  Peer
- Fabien Maldonado, MD, FCCP
  Peer
1
CME/CE
Bronchoscopy, EBUS-TBNA, and CT-Guided Biopsy
Bronchoscopy, EBUS-TBNA, and CT-Guided Biopsy
1.00 credits
- Septimiu Murgu, MD, FCCP
  Peer
- Eric Edell, MD, FCCP
  Peer
- Nichole Tanner, MD, MS, FCCP
  Peer
- Kimberly Sivertsen, APRN-BC
  Peer
- Janani Reisenauer, MD
  Peer
- Andreas Rimner, MD
  Peer
4
CME/CE
Lung Cancer Screening and Treatment of Early Stage
Lung Cancer Screening and Treatment of Early Stage
1.00 credits
- Sagar Lonial, MD
  Peer
- Noopur Raje, MD
  Peer
2
CME/CE
Novel Clinical Approaches in Multiple Myeloma: CAR T Cell Therapy
Novel Clinical Approaches in Multiple Myeloma: CAR T Cell Therapy
0.25 credits

1
Medical Industry Feature
HER2 (ERBB2) Mutations in NSCLC: Mechanism of Disease
HER2 (ERBB2) Mutations in NSCLC: Mechanism of Disease
- Charles Turck, PharmD, BCPS, BCCCP
  Peer
- Jens Hillengass, MD, PhD
  Peer
1
Medical Industry Feature
Investigating Imaging Techniques in Multiple Myeloma
Investigating Imaging Techniques in Multiple Myeloma
- Gary D. Steinberg, MD
  Peer
1
Medical Industry Feature
Exploring High-Risk Non-muscle Invasive Bladder Cancer (NMIBC)
Exploring High-Risk Non-muscle Invasive Bladder Cancer (NMIBC)
- Ian McFadden, Ph.D
  Peer
- Lenora Johnson- Patient
  Peer
- Kimberley Boshell, R.N.
  Peer
- Luciano Costa, M.D., Ph.D.
  Peer
1
Project Oncology®
Addressing Health Disparities for Black/African American Patients with Multiple Myeloma, Topic 1: Patient Experiences & How to Improve Diversity in Clinical Trials
Addressing Health Disparities for Black/African American Patients with Multiple Myeloma, Topic 1: Patient Experiences & How to Improve Diversity in Clinical Trials
- Ian McFadden, Ph.D
  Peer
- Lenora Johnson- Patient
  Peer
- Kimberley Boshell, R.N.
  Peer
- Luciano Costa, M.D., Ph.D.
  Peer
1
Project Oncology®
Addressing Health Disparities for Black/African American Patients with Multiple Myeloma, Topic 2: Patient Journey & Education/Support
Addressing Health Disparities for Black/African American Patients with Multiple Myeloma, Topic 2: Patient Journey & Education/Support
- Joel Neal, MD, PhD
  Peer
- Alexander Spira, MD, PhD, FACP
  Peer
1
Medical Industry Feature
Emerging Therapies for EGFR Exon 20 Insertion–Positive NSCLC
Emerging Therapies for EGFR Exon 20 Insertion–Positive NSCLC

cancertherapyadvisor.com
06/28/2022
Medical News
Men with Breast Cancer Present at Later Stage, Have Worse Prognosis Than Women
Read more
esmo.org
06/28/2022
Medical News
Risk of Anal Cancer Significantly Lower with Treatment For Anal High-Grade Squa…
Read more
newswise.com
06/24/2022
Medical News
MD Anderson & Turning Point Therapeutics Announce Strategic Alliance to Advance…
Read more
labblog.uofmhealth.org
06/23/2022
Medical News
How MRI & CT Predict Flap Failure After Head & Neck Reconstructive Cancer Surge…
Read more
medicalxpress.com
06/22/2022
Medical News
COVID-19 Vaccines Safe for Patients Treated for Lung Cancer with Immune Checkpo…
Read more
medicalxpress.com
06/22/2022
Medical News
Breast Cancer Spreads at Night: Surprising Findings from Cancer Research
Read more

Segment Chapters

Playlist:

Recommended

Webpack App